- Forums
- ASX - By Stock
- TRI
- Ann: FDA Strategy and Regulatory Update
Ann: FDA Strategy and Regulatory Update, page-144
-
-
- There are more pages in this discussion • 549 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
0.001(2.86%) |
Mkt cap ! $16.91M |
Open | High | Low | Value | Volume |
3.5¢ | 3.7¢ | 3.5¢ | $34.06K | 930.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 614003 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 84387 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 614003 | 0.035 |
3 | 313852 | 0.034 |
2 | 184465 | 0.033 |
2 | 206000 | 0.032 |
4 | 485484 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 84387 | 2 |
0.038 | 678000 | 6 |
0.039 | 485606 | 3 |
0.040 | 307529 | 6 |
0.041 | 275000 | 2 |
Last trade - 13.50pm 15/07/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online